Preventive Effect of Acetyl-L-carnitine on Oxaliplatin-induced Peripheral Neuropathy
Condition(s):Acetylcarnitine; Chemotherapy-induced Peripheral NeuropathyLast Updated:November 1, 2022Not yet recruiting
Include Studies Not Open or Pending
Condition(s):Acetylcarnitine; Chemotherapy-induced Peripheral NeuropathyLast Updated:November 1, 2022Not yet recruiting
Condition(s):Peripheral NeuropathyLast Updated:January 30, 2024Not yet recruiting
Condition(s):Diabetic Peripheral Neuropathy Type 2Last Updated:August 19, 2022Recruiting
Condition(s):Chemotherapy-induced Peripheral NeuropathyLast Updated:August 24, 2022Not yet recruiting
Condition(s):Chemotherapy-induced Peripheral Neuropathy (CIPN)Last Updated:January 19, 2024Recruiting
Condition(s):Diabetic Peripheral NeuropathyLast Updated:March 12, 2024Recruiting
Condition(s):Chemotherapy-induced Peripheral Neuropathy; Nerve PainLast Updated:December 28, 2023Recruiting
Condition(s):Diabetic Neuropathy PeripheralLast Updated:September 29, 2022Not yet recruiting
Condition(s):Chemotherapy-induced Peripheral Neuropathy; Pain; Solid TumorLast Updated:February 15, 2023Recruiting
Condition(s):Peripheral NeuropathyLast Updated:January 16, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.